http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020167996-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d51e68100f34990cd8e826158ff2c890
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-42
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-864
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
filingDate 2020-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae1fe89dec1ccc59aaa11a9472b37818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_492006debbba1f4eb7e060b50198e2d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d279bfa3ab9211863fe6e1e16c5a0a3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_149ec49e4cab3b4cabe9659d0bc71152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4964c2813e41b8cc6b3ef98090995f49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73d7c27a51c2d621be72f4b9bb0a3879
publicationDate 2020-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2020167996-A1
titleOfInvention Gene therapy vectors for treatment of danon disease
abstract The present disclosure provides gene therapy vectors comprising a polynucleotide sequence encoding a LAMP-2 polypeptide, methods of use thereof, pharmaceutical compositions, and more. In particular, the disclosure provides recombinant AAV vectors having AAVrh74 serotype expressing LAMP-2A, LAMP-2B, or LAMP-2C for use as a therapeutic in, for example, Danon Disease.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3820537-A4
priorityDate 2019-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017127565-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020014523-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020033842-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015111955-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019038773-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226445867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426571

Total number of triples: 38.